Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Marie Skłodowska-Curie Action · Running

NANOREMEDI Functional Nano-Scaffolds for Regenerative Medicine

Coordinator
Universita Degli Studi Di Milano, Italy
Runs
1 September 2022 to 30 November 2026
Status
Running
EU funding
€3.4m
Total cost
—
Partners
19 organisations in 5 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101072645

What the project is doing

In the project's own words, from its summary on CORDIS.

Repair or replacement of tissue and organ functions lost due to age, disease or damage represents one of the most urgent medical needs of our aging society. The NanoReMedi Consortium will contribute to addressing this fundamentally important issue by using a new and efficient scientific approach relying on the design, preparation, characterization and validation of conceptually innovative peptide-based functional nanomaterials for regenerative medicine applications.

Specifically, NanoReMedi will tackle three highly relevant case studies: “Tissue engineered vascular grafts to replace damaged peripheral arteries”, “Stem-cell based regenerative medicine for bone and cartilage repair” and “Facing with implantation failure” this last addressed to overcome bacterial severe infections. As an equally important goal, the NanoReMedi Consortium aims to build a world-class doctoral educational model in the field of nanomaterials applied to regenerative nanomedicine, through a strategically designed Academia-Industry interplay.

To this end, 6 Beneficiaries, one Associated Partner linked to a beneficiary and 12 non-academic associated partners will join their forces to: i)create a highly innovative research network for training a new generation of 13 Doctoral Candidates (DCs) with strong employment potential, aimed at studying and developing “Functional Nano-Scaffolds for Regenerative Medicine”; ii)establish a robust structure for long-term research cooperation between a pool of leading Universities and Enterprises, for broadening and strengthening the knowledge and skills of DCs accessing the nanoscience-area from adjacent disciplines (such as chemistry, material sciences and bioinformatics); iii)building a solid foundation for long-term European excellence in medical nanotechnology via dissemination of research/training outcomes - through cross-network secondments, Summer Schools workshops and transferable skills modules, and of the best practice generated by NanoReMedi.

Topics

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di MilanoMilanoItalyCoordinator
Edelweiss Connect GmbHBaselSwitzerlandAssociatedpartner
Asociacion Centro De Investigacion Cooperativa En Nanociencias Cic NanoguneSan SebastianSpainParticipant
Ponti & Partners, SLPBarcelonaSpainAssociatedpartner
Simune Atomistics SLDonostia San SebastianSpainAssociatedpartner
Universidad Del Pais Vasco/ Euskal Herriko UnibertsitateaLeioaSpainAssociatedpartner
Universitat Politecnica De CatalunyaBarcelonaSpainParticipant
Genepep SASaint Jean De VedasFranceAssociatedpartner
LynxterBayonneFranceAssociatedpartner
Universite De MontpellierMontpellierFranceParticipant
The Hebrew University of JerusalemJerusalemIsraelParticipant
AB Medica SpAMilanoItalyAssociatedpartner
Bayer HealthCare Manufacturing S.r.l.MilanoItalyAssociatedpartner
Bio Basic Europe S.r.l.MilanoItalyAssociatedpartner
De Lama spaSan Martino SiccomarioItalyAssociatedpartner
Italfarmaco S.p.a.MilanoItalyAssociatedpartner
Jacobacci & Partners S.p.A.TorinoItalyAssociatedpartner
Officine Innovazione SRL Societa' BenefitMilanoItalyAssociatedpartner
Universita Degli Studi Di PaviaPaviaItalyParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI